Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Pathology

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9896(199808)185:4<435::AID-PATH129>3.0.CO;2-0PMID 9828844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors

  1997cited by this paper
• Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

  1997cited by this paper
• ERβ: Identification and characterization of a novel human estrogen receptor

  1996cited by this paper
• Multiple Estrogen Function in Human Prostate Cancer Cells a

  1996cited by this paper
• ER beta: identification and characterization of a novel human estrogen receptor.

  1996cited by this paper
• Cloning of a novel receptor expressed in rat prostate and ovary.

  1996cited by this paper
• Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.

  1996cited by this paper
• Sex steroids up-regulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells.

  1995cited by this paper
• Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.

  1995cited by this paper
• Human prostate cancer: a direct role for oestrogens.

  1995cited by this paper
• Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells.

  1994cited by this paper
• Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.

  1991cited by this paper
• Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.

  1990cited by this paper
• The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines.

  1990cited by this paper
• A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.

  1990cited by this paper
• Negative controls of cell proliferation: human prostate cancer cells and androgens.

  1989cited by this paper
• Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

  1988cited by this paper
• Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein.

  1987cited by this paper
• Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.

  1987cited by this paper
• Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP

  1986cited by this paper

• The role of steroid hormone receptors in prostate cancer.A study of estrogen- and progesterone receptors in adenocarcinoma of the prostate

  2018cites this paper
• Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα

  2017cites this paper
• Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer

  2016cites this paper
• Ekspresija estrogenog receptora β u prekanceroznim lezijama i adenokarcinomu prostate

  2016cites this paper
• High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure

  2015cites this paper
• Estrogen induces androgen‐repressed SOX4 expression to promote progression of prostate cancer cells

  2015cites this paper
• Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity

  2014cites this paper
• HORMONAL DISTURBANCES IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA

  2013cites this paper
• DNA methylation in promoter region as biomarkers in prostate cancer.

  2012cites this paper
• SEX STEROID METABOLISM AND ACTION, INFLAMMATION AND PROSTATE CANCER: HYPOTHETICAL MECHANISMS AND NETWORKS

  2012cites this paper
• Aberrant DNA Methylation and Prostate Cancer

  2011cites this paper
• Transcriptional coactivators p300 and CBP stimulate estrogen receptor‐beta signaling and regulate cellular events in prostate cancer

  2011cites this paper
• Expression of estrogen alpha and beta receptors in prostate cancer and hyperplasia: Immunohistochemical analysis

  2010cites this paper
• Promoter hypermethylation in prostate cancer.

  2010cites this paper
• Invasive Lobular Carcinoma of the Male Breast: A Rare Histology in an Uncommon Disease

  2009cites this paper
• In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol

  2008cites this paper
• Epigenetics of prostate cancer.

  2007cites this paper
• AWARD NUMBER: W81XWH-04-1-0198 TITLE: Evaluation of Roles of Interferon Gamma Regulated Genes in Inhibition of Androgen-Independent Prostate Cancer

  2006cites this paper
• Differential Expression in Estrogen Receptor alpha ( ESR α ) and beta ( ESR β ) in breast ( MCF-7 ) and prostate ( PC 3 ) cell lines

  2006cites this paper
• Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

  2005cites this paper
• Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.

  2005cites this paper
• The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer.

  2004cites this paper
• Immunohistochemical Study Of Bcl-2 Protein And Estrogen Receptor-Alpha Expression In Benign Prostatic Hyperplasia And Prostatic Carcinoma

  2004cites this paper
• PC‐3 cells with enhanced androgen receptor signaling: A model for clonal selection in prostate cancer

  2004cites this paper
• Regulation of normal and malignant prostate cell biology by IGF-I: mechanisms and modulation by dietary polyphenols and energy restriction

  2003cites this paper
• Expression of ERα and ERβ in prostate cancer

  2003cites this paper
• Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.

  2003cites this paper
• Zone-Dependent Expression of Estrogen Receptors and in Human Benign Prostatic Hyperplasia

  2003cites this paper
• CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors.

  2002cites this paper
• Effect of fatty acids on estradiol and testosterone binding to whole DU-145 prostate cells.

  2002cites this paper
• PROGINS-polymorphism in the human progesterone receptor gene : a potential genetic risk factor for prostate cancer ?

  2002cites this paper
• Flavonoids can block PSA production by breast and prostate cancer cell lines.

  2002cites this paper
• CGA gene (Coding for the α subunit of glycoprotein hormones) overexpression in ERα-positive prostate tumors

  2002cites this paper
• Effect of Resveratrol on the Expression of Autocrine Growth Modulators in Human Breast Cancer Cells

  2001cites this paper
• Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

  2001cites this paper
• CpG hypermethylation of the promoter region inactivates the estrogen receptor‐β gene in patients with prostate carcinoma

  2001cites this paper
• Estrogen and Antiestrogen Actions on Human Prostate Cancer: A Dissertation

  2001cites this paper
• Expression of Estrogen Receptor (ER–α and ER–β) mRNA in Human Prostate Cancer

  2001cites this paper
• Inhibition of growth and cell cycle arrest of ARCaP human prostate cancer cells by ectopic expression of ER-α

  2001cites this paper
• Chain Reaction Assays by Real-Time Quantitative Reverse Transcription-Polymerase Progesterone Receptor Expression in Human Prostate Cancer ) , and β ER and α ER Evaluation of Androgen , Estrogen ( Updated

  2001cites this paper
• Estrogen receptors (cid:1) and (cid:2) in the normal, hyperplastic and carcinomatous human prostate

  2001cites this paper
• Expression of Estrogen Receptor ( ER )-a and ERb in Normal and Malignant Prostatic Epithelial Cells : Regulation by Methylation and Involvement in Growth Regulation 1

  2000cites this paper
• Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

  2000cites this paper
• Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.

  2000cites this paper
• Methylation and Involvement in Growth Regulation and Malignant Prostatic Epithelial Cells : Regulation by in Normal β and ER-α Expression of Estrogen Receptor ( ER )-Updated Version

  2000cites this paper
• Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.

  1999cites this paper
• Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells

  1999cites this paper
• The Prostate 48 : 285 ^ 291 ( 2001 ) ProgesteroneReceptor Expression inHuman ProstateCancer : CorrelationWith TumorProgression

  year unknowncites this paper